Showing results (241-250 of 281) with videos related to
Sort By:
Pageof 29
Cancer Research Communications|April 9, 2024
Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent "NoGlow" MiceTimothy N Trotter, Andrea Wilson, Jason McBane, et al.Annals of Surgery|February 19, 2026
Automated Non-Invasive Burn Diagnostic System for Healthcare using Artificial Intelligence: AMBUSH-AIMohamed El Masry, Md Masudur Rahman, Surya C Gnyawali, et al.Cancer Research|May 6, 2020
IL26, a Noncanonical Mediator of DNA Inflammatory Stimulation, Promotes TNBC Engraftment and Progression in Association with NeutrophilsTimothy N Trotter, Casey W Shuptrine, Li-Chung Tsao, et al.Journal of Endourology|January 8, 2024
Not All Flat-Panel C-Arms Are Created Equal: A Comparison of Three Major ManufacturersStephanie Jensen, Daniel R Peverini, Akin S Amasyali, et al.Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|April 17, 2020
A nonsurgical approach with repeated orthoptic evaluation is justified for most blow-out fracturesJesper Jansen, Leander Dubois, Thomas J J Maal, et al.Urologic Oncology|October 6, 2024
Quantifying preserved renal volume and function in patients undergoing standard partial nephrectomy vs. tumor enucleation for localized renal tumorsJeffrey L Ellis, Isaac Sontag-Milobsky, Victor S Chen, et al.Journal for Immunotherapy of Cancer|November 12, 2020
Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratioErika J Crosby, Amy C Hobeika, Donna Niedzwiecki, et al.Vaccines|November 26, 2024
Vaccination Against Androgen Receptor Splice Variants to Immunologically Target Prostate CancerRobert D Marek, Selena Halabi, Mu-En Wang, et al.Breast Cancer Research : BCR|August 11, 2018
Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancersTakuya Osada, Zachary C Hartman, Junping Wei, et al.Oncoimmunology|May 17, 2017
Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapyJun Ren, William R Gwin, Xinna Zhou, et al.Pageof 29